Aureus Asset Management »

Oncternal Therapeutics shares owned by Aureus Asset Management

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by Aureus Asset Management from 13F filings

Historical chart of Aureus Asset Management investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Aureus Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Aureus Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 30k 0.54

More positions owned by Aureus Asset Management

Microsoft Corporation Stock (MSFT)
Amazon.Com Stock (AMZN)
Blackstone Group Stock (BX)
Alphabet Inc. Class A Stock (GOOGL)
Apple Stock (AAPL)
Visa Inc. Class A Stock (V)
Charles Schwab Corporation Stock (SCHW)
Unitedhealth Group Incorporated Stock (UNH)
Meta Platforms Stock (META)
S&P Global Stock (SPGI)
Adobe Systems Incorporated Stock (ADBE)
Salesforce.Com Stock (CRM)
American Tower Corporation Reit (AMT)
Booz Allen Hamilton Holding Corporation Class A Stock (BAH)
Charter Communications, Inc. Class A Stock (CHTR)

View all positions for Aureus Asset Management

Top funds holding Oncternal Therapeutics

Aureus Asset Management
North Star Investment Management
Bnp Paribas Arbitrage, Snc
Lindbrook Capital

View all funds holding Oncternal Therapeutics